Site Director: Randy J. Maddux
GSK is a science-led global healthcare company which researches and develops a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. Headquartered in the United Kingdom, GSK has a significant global presence with commercial operations in more than 150 countries, including a biopharmaceutical manufacturing facility in Rockville. The facility is part of GSK Global Manufacturing and Supply (GMS), which makes biopharmaceutical drug substance for clinical trials and commercial use. The Rockville biopharm site consists of two FDA-licensed facilities for large and small scale manufacturing, which employ more than 420 highly-skilled scientists, engineers and manufacturing and quality professionals among other specialists.
Why Rockville: GSK began operations in Maryland in 2012, when the company acquired Human Genome Sciences, which was founded in Rockville in 1992. GSK remains committed to Maryland for its proximity to leading scientific and academic institutions and the nation’s capital, as well as for the area’s highly skilled workforce and advanced transportation infrastructure.
Find GSK Biopharmaceutical at BIO: Booth 5344.
CEO: Kevin Sexton
About Holy Cross Germantown Hospital: The hospital is the first in the nation to be located on the campus of a community college – Montgomery County Community College - Germantown Campus – and the first new hospital in Montgomery County in 35 years.
The state-of-the-art facility boasts the latest technology—and the expertise of a skilled team of health care professionals. The hospital is designed with patients’ safety, healing and comfort in mind. It is environmentally friendly, featuring green space, and all private rooms.
Holy Cross Germantown Hospital’s top quality specialty services include: a full service emergency department for adults, seniors and children, trusted maternity care for mothers and their newborns, state-of-the art diagnostic and surgical services, and emergency and voluntary inpatient psychiatric care.
The partnership between Holy Cross Health and Montgomery County Community College was established in 2004 with the opening of the Holy Cross Health Center on their Takoma Park campus. This new venture represents a model for similar partnerships throughout the nation. "The expansion of clinical rotations for our students is significant, as we look to the future and our goal of sustaining a positive economic impact for Montgomery County and Maryland,” said Dr. DeRionne P. Pollard, president of Montgomery College. “Education and health care are intricately and intimately connected to the wellbeing of the community. When they thrive together, the community thrives as well."
PIC MC is easy on and off 270 with MC students as future workforce; close to fastest growing area in Maryland..
(Photograph and content courtesy of Holy Cross Hospital)
Vice President & Head, U.S. Vaccines R&D Center: Ripley Ballou
About GSK: The soon-to-open GSK Global Vaccines US R&D Center is a critical component of GSK and its vision of being the leader in the field of vaccines. The state-of-the-art facility will be at the forefront of vaccine research and development, combatting some of the most important diseases known to man and addressing the medical needs of people of all ages around the world. It is home to some of the best scientific minds in vaccine research and development, who will work collaboratively with the Vaccines R&D centers in Italy and Belgium.
Why Rockville: Located in the research-rich Washington, D.C., area, the center establishes a vital footprint for GSK Vaccines in the U.S. market and serves as a center of research and development excellence in the world’s largest healthcare market. The Center’s proximity to world-renowned academic centers, government-owned laboratories, U.S. government institutions, and external partners will allow the company to reinforce and build new relationships with key scientists and organizations, and access major funding and research resources.
CEO: Peter Greenleaf
About Sucampo: Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a pipeline of product candidates in clinical development. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K.
Why Rockville: At a time of rapid growth and advancement for Sucampo, we chose to make our home in Rockville, a central location in Maryland’s biotechnology corridor.
CEO: Bahija Jallal, Ph. D., Executive Vice President, Astrazeneca and Head of MedImmune
Founded: 1988 as Molecular Vaccines, Inc.; name changed to MedImmune in 1990
About MedImmune: A leading global biologics R&D powerhouse, MedImmune comprises nearly half of AstraZeneca’s overall R&D portfolio and currently has more than 120 research projects and product candidates. The company’s focus includes three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease.
Why Gaithersburg: The company was born here, and acquired by Astra Zeneca in 2007. Today, Gaithersburg is home to MedImmune’s headquarters with 2500 employees.
Summary: FITCI is a non-profit organization created for local entrepreneurs seeking offices, laboratory facilities, and entrepreneurial support services. FITCI's goal is to foster entrepreneurship in Frederick County and accelerate the development of commercially viable businesses generating continued job growth. FITCI is supported by the State of Maryland Department of Commerce, Maryland Technology Development Corporation, Frederick County, The City of Frederick, and the local business community.
CEO: Willie E. May, Director and Under Secretary of Commerce for Standards and Technology
Summary: NIST's mission is to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve our quality of life.
Originally known as the Office of Standard Weights and Measures, Congress created an agency in 1824 within the Treasury Department to establish and promote the consistent use of uniform weights and measures. By the early 1900s the name had changed to the National Bureau of Standards and the organization had moved to the Department of Commerce. By 1956, the Bureau was lobbying to move from Washington, DC. In 1988, the name changes to the National Institute of Standards and Technology.
Commanding General: Major General Brian Lein
Garrison Commander: Colonel Robert Anthony O'Brien IV
Summary: The US Army Garrison, Fort Detrick, supports five cabinet-level agencies: The Department of Defense, Department of Veterans Affairs, Department of Agriculture, Department of Homeland Security and Department of Health and Human Services.
Within the DoD, Fort Detrick supports elements of all four military services. Major Department of the Army mission partners include the US Army Medical Research and Materiel Command and the 21st Signal Brigade.
COO: David Bufter
Summary: The Frederick National Laboratory for Cancer Research (FNLCR) is a federal national laboratory operated by Leidos Biomedical Research, Inc. under sponsorship of the National Cancer Institute, part of the U.S. National Institutes of Health. The Frederick National Lab collaborates with public and private partners to address urgent problems in biomedical research -- to discover, to innovate, and to improve human health.
Co-Founder: Dr. Robert F. Garry
About Zalgen Labs: The Pinkney Innovation Complex for Science and Technology is thrilled to share the success story of an entrepreneur in the Montgomery County owned incubator, The Germantown Innovation Center, located within PIC MC called Zalgen Labs, LLC.
Zalgen Labs is a biotechnology company specializing in the design and production of superior biological molecules critical for the development and commercialization of immunotherapeutics, novel vaccines, and reliable, rapid, and affordable diagnostic platforms targeting neglected and underrepresented human infectious diseases. The company makes use of its proprietary expression platforms, including its patented mammalian cell-based biomanufacturing system.
(Content courtesy of Zalgen Labs, LLC)